Published in Acta Derm Venereol on January 01, 2002
Significance of dermoscopic patterns in detecting malignant melanoma on acral volar skin: results of a multicenter study in Japan. Arch Dermatol (2004) 2.62
Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression. Mol Pharmacol (2005) 2.44
Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J Immunol (2010) 1.98
Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts. J Immunol (2005) 1.81
Interleukin-12 p40 gene (IL12B) 3'-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J Dermatol Sci (2002) 1.75
Isolation of murine hair-inducing cells using the cell surface marker prominin-1/CD133. J Invest Dermatol (2006) 1.64
The repeat domain of the melanosomal matrix protein PMEL17/GP100 is required for the formation of organellar fibers. J Biol Chem (2006) 1.46
Increased expression of integrin alphavbeta5 induces the myofibroblastic differentiation of dermal fibroblasts. Am J Pathol (2006) 1.46
Henoch-Schönlein purpura in a patient with rheumatoid arthritis receiving etanercept. Eur J Dermatol (2010) 1.39
Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. J Dermatol Sci (2006) 1.33
Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts. J Clin Invest (2004) 1.32
Involvement of alphavbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts. Arthritis Rheum (2005) 1.32
Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Oncogene (2004) 1.24
CD19 expression in B cells is important for suppression of contact hypersensitivity. Am J Pathol (2007) 1.20
Specific inhibition of human skin fibroblast chemotaxis to platelet-derived growth factor A-chain homodimer by transforming growth factor-beta1. Arch Dermatol Res (2002) 1.19
CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes. Blood (2003) 1.18
Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Ets1 and Fli1. Nucleic Acids Res (2005) 1.16
Mechanical stretching in vitro regulates signal transduction pathways and cellular proliferation in human epidermal keratinocytes. J Invest Dermatol (2004) 1.14
Antagonistic effects of TNF-alpha on TGF-beta signaling through down-regulation of TGF-beta receptor type II in human dermal fibroblasts. J Immunol (2003) 1.14
Transcriptional profiling of epidermal differentiation. Physiol Genomics (2006) 1.13
Alpha2(I) collagen gene regulation by protein kinase C signaling in human dermal fibroblasts. Nucleic Acids Res (2005) 1.12
Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released protein. FASEB J (2010) 1.12
Possible roles of IL-27 in the pathogenesis of psoriasis. J Invest Dermatol (2009) 1.12
Characterization and localization of side population cells in mouse skin. Stem Cells (2005) 1.09
Involvement of alphavbeta5 integrin in the establishment of autocrine TGF-beta signaling in dermal fibroblasts derived from localized scleroderma. J Invest Dermatol (2006) 1.09
Phosphatidylinositol 3-kinase is involved in alpha2(I) collagen gene expression in normal and scleroderma fibroblasts. J Immunol (2004) 1.08
Characterization of a mouse second leukotriene B4 receptor, mBLT2: BLT2-dependent ERK activation and cell migration of primary mouse keratinocytes. J Biol Chem (2005) 1.06
A randomized double-blind trial of intravenous immunoglobulin for pemphigus. J Am Acad Dermatol (2009) 1.06
Constitutive phosphorylation of focal adhesion kinase is involved in the myofibroblast differentiation of scleroderma fibroblasts. J Invest Dermatol (2005) 1.03
LPA4 regulates blood and lymphatic vessel formation during mouse embryogenesis. Blood (2010) 1.03
Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides. J Am Acad Dermatol (2003) 1.02
B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse. Am J Pathol (2004) 1.02
Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. J Allergy Clin Immunol (2003) 1.01
Prevalence of atopic dermatitis in Japanese adults and community validation of the U.K. diagnostic criteria. J Dermatol Sci (2009) 1.00
Clinical and laboratory features of scleroderma patients developing skeletal myopathy. Clin Rheumatol (2004) 1.00
Characterization of mouse cysteinyl leukotriene receptors mCysLT1 and mCysLT2: differential pharmacological properties and tissue distribution. J Biol Chem (2002) 1.00
Differential expression and function of Toll-like receptors in Langerhans cells: comparison with splenic dendritic cells. J Invest Dermatol (2004) 1.00
The long-term safety of adalimumab treatment in moderate to severe psoriasis: a comprehensive analysis of all adalimumab exposure in all clinical trials. Am J Clin Dermatol (2011) 0.99
Eotaxins and CCR3 interaction regulates the Th2 environment of cutaneous T-cell lymphoma. J Invest Dermatol (2010) 0.99
Increased expression levels of integrin alphavbeta5 on scleroderma fibroblasts. Am J Pathol (2004) 0.98
CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells. Int Immunol (2007) 0.98
The secreted form of a melanocyte membrane-bound glycoprotein (Pmel17/gp100) is released by ectodomain shedding. FASEB J (2009) 0.97
P2Y6 receptor signaling pathway mediates inflammatory responses induced by monosodium urate crystals. J Immunol (2011) 0.96
Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-beta signaling in cultured scleroderma fibroblasts. Am J Pathol (2005) 0.96
Japanese guideline for atopic dermatitis. Allergol Int (2011) 0.96
Serum high molecular weight adiponectin levels are decreased in psoriasis patients. J Dermatol Sci (2009) 0.96
TNF, but not IL-6 and IL-17, is crucial for the development of T cell-independent psoriasis-like dermatitis in Il1rn-/- mice. J Immunol (2010) 0.95
Effects of hepatocyte growth factor on the expression of type I collagen and matrix metalloproteinase-1 in normal and scleroderma dermal fibroblasts. J Invest Dermatol (2005) 0.95
Macrophage-derived chemokine (MDC)/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis. J Dermatol Sci (2006) 0.95
Thymus and activation-regulated chemokine (TARC/CCL17) produced by mouse epidermal Langerhans cells is upregulated by TNF-alpha and IL-4 and downregulated by IFN-gamma. Cytokine (2003) 0.94
CD22 expression mediates the regulatory functions of peritoneal B-1a cells during the remission phase of contact hypersensitivity reactions. J Immunol (2010) 0.94
Interleukin-13 gene polymorphism G4257A is associated with atopic dermatitis in Japanese patients. J Dermatol Sci (2002) 0.94
Prevalence of atopic dermatitis determined by clinical examination in Japanese adults. J Dermatol (2006) 0.94
Skin manifestations of arsenicosis in two villages in Bangladesh. Int J Dermatol (2002) 0.94
Laser treatment of 26 Japanese patients with Mongolian spots. Dermatol Surg (2008) 0.94
Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin. J Invest Dermatol (2005) 0.93
Upregulated expression of transforming growth factor-beta receptors in dermal fibroblasts of skin sections from patients with systemic sclerosis. J Rheumatol (2002) 0.93
Anti-cyclic citrullinated peptide antibodies and IL-23p19 in psoriatic arthritis. J Dermatol Sci (2008) 0.93
CCL27-transgenic mice show enhanced contact hypersensitivity to Th2, but not Th1 stimuli. Eur J Immunol (2008) 0.92
Interleukin-13 stimulates the transcription of the human alpha2(I) collagen gene in human dermal fibroblasts. J Biol Chem (2004) 0.92
Regulation of fibrogenic/fibrolytic genes by platelet-derived growth factor C, a novel growth factor, in human dermal fibroblasts. J Cell Physiol (2005) 0.92
The human histocompatibility leukocyte antigen (HLA) haplotype is associated with the onset of postherpetic neuralgia after herpes zoster. Pain (2004) 0.92
IL-4 up-regulates the expression of tissue inhibitor of metalloproteinase-2 in dermal fibroblasts via the p38 mitogen-activated protein kinase dependent pathway. J Immunol (2002) 0.91
CCL17 transgenic mice show an enhanced Th2-type response to both allergic and non-allergic stimuli. Eur J Immunol (2006) 0.90
Generalized eruptive syringoma. Pediatr Dermatol (2005) 0.90
B cell antigen receptor and CD40 differentially regulate CD22 tyrosine phosphorylation. J Immunol (2006) 0.90
Differential production of Th1- and Th2-type chemokines by mouse Langerhans cells and splenic dendritic cells. J Invest Dermatol (2005) 0.90
Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid. J Dermatol Sci (2007) 0.90
A keratin 10 gene mutation (Arg156Cys) in a Japanese patient with bullous congenital ichthyosiform erythroderma. J Dermatol (2002) 0.90
Japanese guidance for use of biologics for psoriasis (the 2013 version). J Dermatol (2013) 0.90
Does thrombosis cause intravascular fasciitis? Acta Derm Venereol (2007) 0.89
Community validation of the U.K. diagnostic criteria for atopic dermatitis in Japanese elementary schoolchildren. J Dermatol Sci (2007) 0.89
Elevated serum CTACK/CCL27 levels in CTCL. J Invest Dermatol (2006) 0.89
Blue naevus with pigment network-like structure on dermoscopy. Acta Derm Venereol (2008) 0.89
Lichen planus pigmentosus-inversus occurring extensively in multiple intertriginous areas. J Dermatol (2011) 0.88
Cholinergic urticaria successfully treated with scopolamine butylbromide. Int J Dermatol (2003) 0.88
Eccrine angiomatous hamartoma with massive mucin deposition. Eur J Dermatol (2005) 0.88
The direct action of 1alpha,25(OH)2-vitamin D3 on purified mouse Langerhans cells. Cell Immunol (2007) 0.88
Platelet derived growth factor induced tenascin-C transcription is phosphoinositide 3-kinase/Akt-dependent and mediated by Ets family transcription factors. J Cell Physiol (2006) 0.88
Recurrent cutaneous eosinophilic vasculitis presenting as annular urticarial plaques. Acta Derm Venereol (2005) 0.87
Both IL-4 and IL-13 inhibit the TNF-alpha and IFN-gamma enhanced MDC production in a human keratinocyte cell line, HaCaT cells. J Dermatol Sci (2003) 0.87
Variations in the human Th2-specific chemokine TARC gene. Immunogenetics (2003) 0.86
Interleukin 15 induces the signals of epidermal proliferation through ERK and PI 3-kinase in a human epidermal keratinocyte cell line, HaCaT. Biochem Biophys Res Commun (2003) 0.86
Serum thymic stromal lymphopoietin levels are not elevated in patients with atopic dermatitis. J Dermatol (2008) 0.86
Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes. Eur J Immunol (2009) 0.86
Potential regulatory elements of the constitutive up-regulated alpha2(I) collagen gene in scleroderma dermal fibroblasts. Biochem Biophys Res Commun (2006) 0.85
CCL11-CCR3 interactions promote survival of anaplastic large cell lymphoma cells via ERK1/2 activation. Cancer Res (2011) 0.85
Epidermal growth factor induces fibronectin expression in human dermal fibroblasts via protein kinase C delta signaling pathway. J Invest Dermatol (2004) 0.85
Lymphatic dysfunction impairs antigen-specific immunization, but augments tissue swelling following contact with allergens. J Invest Dermatol (2011) 0.85